외래수술센터(ASC) 시장 예측(-2030년) : 부문별 분석

According to Stratistics MRC, the Global Ambulatory Surgical Centers Market is accounted for $4.45 billion in 2023 and is expected to reach $24.48 billion by 2030 growing at a CAGR of 27.6% during the forecast period. Ambulatory surgical centers are healthcare facilities that provide same-day surgical care, allowing patients to undergo procedures without overnight hospitalization. Equipped with advanced medical technology, ASCs offer a wide range of surgical procedures, from routine to complex, in specialties like orthopedics, ophthalmology, and gastroenterology. These centers promote efficiency, convenience, and cost-effectiveness compared to traditional hospital settings. ASCs play a crucial role in modern healthcare, offering personalized treatment in a comfortable outpatient setting.

According to the Federated Ambulatory Surgery Association (FASA) Outcomes Monitoring Projects 2021, 75% of ASCs started 95% of their cases on time.

Market Dynamics:

Driver:

Increasing elderly population

The burgeoning elderly population simultaneously raises age-related health issues necessitating surgical interventions. ASCs cater to this demographic by offering efficient, cost-effective outpatient surgeries, aligning with the preferences of both patients and payers. These centers provide a convenient alternative to traditional hospital settings, offering specialized care tailored to the needs of older adults while ensuring quicker recovery times and reduced infection risks. Consequently, the increasing demand for surgical procedures among the elderly is fueling the expansion of the ASC market.

Restraint:

Limited procedure scope

The limited procedure scope in ASCs arises from regulatory restrictions and resource constraints. ASCs are typically equipped for low-risk, short-duration procedures, such as cataract surgery or endoscopy, due to space, staffing, and equipment limitations. This constrained scope restricts ASCs from catering to complex or prolonged surgeries, limiting their market reach. Consequently, patients requiring such procedures are often directed to hospitals, hindering ASCs' market growth potential.

Opportunity:

Escalating regulatory support

Regulatory bodies increasingly recognize ASCs as safe, cost-effective alternatives to traditional hospital settings for outpatient procedures. This recognition translates into streamlined accreditation processes, favourable reimbursement policies, and enhanced operational standards, encouraging the proliferation of ASCs. Moreover, stringent regulatory oversight assures patients of quality care and safety standards, fostering trust and confidence in ASCs. Consequently, this regulatory backing stimulates investments in ASC infrastructure and services, driving market expansion and meeting the rising demand for outpatient surgical procedures.

Threat:

Inconsistent reimbursement policies

Inconsistent reimbursement policies in ASCs stem from variations across different payers, including government programs and private insurers. These disparities create uncertainty for ASCs regarding reimbursement rates and coverage, making financial planning challenging. Additionally, frequent changes in reimbursement rules can lead to administrative burdens and increased operational costs. This inconsistency hampers market growth by discouraging investment in ASCs, limiting expansion opportunities, and potentially reducing patient access to these facilities.

Covid-19 Impact

The covid-19 pandemic significantly impacted ambulatory surgical centers market dynamics. Initially, many ASCs experienced a decline in elective procedures due to lockdowns, restrictions, and patient concerns about virus exposure. This led to revenue losses and operational challenges for ASCs. However, as healthcare systems adapted to pandemic protocols and elective surgeries resumed, ASCs played a vital role in providing safe, efficient surgical care. With their focus on outpatient services and lower infection risks compared to hospitals, ASCs regained momentum, highlighting their resilience and importance in the healthcare landscape amidst the pandemic's challenges.

The surgical services segment is expected to be the largest during the forecast period

The surgical services segment is estimated to have a lucrative growth. ASCs provide a wide range of surgical services in outpatient settings, allowing patients to undergo procedures and return home on the same day. These facilities offer convenience, cost-effectiveness, and efficiency compared to traditional hospital-based surgeries. ASCs are equipped with advanced technology and staffed by skilled healthcare professionals to ensure safe and successful procedures. With a focus on patient-centered care, ASCs continue to play a vital role in the delivery of high-quality surgical services worldwide.

The pain management segment is expected to have the highest CAGR during the forecast period

The pain management segment is anticipated to witness the highest CAGR growth during the forecast period. Pain management in ASCs encompasses various minimally invasive procedures aimed at alleviating acute or chronic pain, often allowing patients to return home on the same day. These procedures are performed by skilled pain management specialists in well-equipped facilities, providing efficient and effective relief for patients. ASCs prioritize patient comfort, safety, and optimal outcomes in pain management interventions.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing demand for cost-effective healthcare solutions, advancements in medical technology, and rising prevalence of chronic diseases. Key countries like China, India, and Japan are experiencing rapid expansion in ASCs due to government initiatives promoting outpatient care and the need to alleviate pressure on traditional hospital settings. Additionally, the adoption of minimally invasive surgeries and the growing aging population further propel market growth, creating lucrative opportunities for market players in the region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the shift towards outpatient procedures, advancements in medical technology, and increasing healthcare expenditure. The United States dominates the market, driven by a strong healthcare infrastructure and favourable reimbursement policies. Additionally, the rise in chronic diseases and the aging population further fuel demand for ASC services. With ongoing innovations and strategic partnerships, the North American ASC market is expected to continue its growth trajectory.

Key players in the market

Some of the key players profiled in the Ambulatory Surgical Centers Market include Ambulatory Surgical Centers of America (ASCOA), AmSurg Corporation, Covenant Physician Partners, Envision Healthcare Corporation, Hospital Corporation of America, Nueterra Healthcare, Regent Surgical Health, Stryker Corporation, Surgery Partners, Surgical Care Affiliates (SCA), Surgical Development Partners LLC, Surgical Management Professionals, Tenet Healthcare Corporation, United Surgical Partners International (USPI) and Xenco Services.

Key Developments:

In June 2022, Xenco Medical has expanded its ASC surgical device portfolio through the FDA clearance and launch of its Multilevel CerviKit(TM), an expansion of Xenco Medical's breakthrough single-use cervical spine technology to include a comprehensive suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.

In March 2022, The Leapfrog Group, a national watchdog organization of employers and other purchasers focused on health care safety and quality, introduced the new Leapfrog Ambulatory Surgery Center (ASC). The Leapfrog Group also uses the Leapfrog Hospital Safety Grade and ASC Surveys to insist that quality and safety are top priorities.

Types Covered:

• Single Speciality Centers
• Multispecialty Centers

Services Covered:

• Diagnostic Services
• Surgical Services
• Therapeutic Services
• Preventive Services
• Rehabilitative Services
• Other Services

Ownerships Covered:

• Physician-Owned ASCs
• Corporate-Owned ASCs
• Hospital-Owned ASCs

Technologies Covered:

• Robotic Surgery
• Minimally Invasive Surgery
• Computer-Assisted Surgery

Applications Covered:

• Ophthalmology
• Gastroenterology
• Pain Management
• Dermatology
• Plastic Surgery
• Urology
• Other Applications

End Users Covered:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Technology Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Ambulatory Surgical Centers Market, By Type

• 5.1 Introduction
• 5.2 Single Speciality Centers
• 5.3 Multispeciality Centers

6 Global Ambulatory Surgical Centers Market, By Service

• 6.1 Introduction
• 6.2 Diagnostic Services
• 6.3 Surgical Services
• 6.4 Therapeutic Services
• 6.5 Preventive Services
• 6.6 Rehabilitative Services
• 6.7 Other Services

7 Global Ambulatory Surgical Centers Market, By Ownership

• 7.1 Introduction
• 7.2 Physician-Owned ASCs
• 7.3 Corporate-Owned ASCs
• 7.4 Hospital-Owned ASCs

8 Global Ambulatory Surgical Centers Market, By Technology

• 8.1 Introduction
• 8.2 Robotic Surgery
• 8.3 Minimally Invasive Surgery
• 8.4 Computer-Assisted Surgery

9 Global Ambulatory Surgical Centers Market, By Application

• 9.1 Introduction
• 9.2 Ophthalmology
• 9.3 Gastroenterology
• 9.4 Pain Management
• 9.5 Dermatology
• 9.6 Plastic Surgery
• 9.7 Urology
• 9.8 Other Applications

10 Global Ambulatory Surgical Centers Market, By End User

• 10.1 Introduction
• 10.2 Hospitals
• 10.3 Specialty Clinics
• 10.4 Ambulatory Surgical Centers
• 10.5 Other End Users

11 Global Ambulatory Surgical Centers Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Ambulatory Surgical Centers of America (ASCOA)
• 13.2 AmSurg Corporation
• 13.3 Covenant Physician Partners
• 13.4 Envision Healthcare Corporation
• 13.5 Hospital Corporation of America
• 13.6 Nueterra Healthcare
• 13.7 Regent Surgical Health
• 13.8 Stryker Corporation
• 13.9 Surgery Partners
• 13.10 Surgical Care Affiliates (SCA)
• 13.11 Surgical Development Partners LLC
• 13.12 Surgical Management Professionals
• 13.13 Tenet Healthcare Corporation
• 13.14 United Surgical Partners International (USPI)
• 13.15 Xenco Services